Cell therapy for cardiac repair

British Medical Bulletin

Volumn 94, Issue 1, 2010, Pages 65-80

  Lee, Joon ^a   Terracciano, Cesare M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiac repair; Heart failure; Stem cells

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BETA1 INTEGRIN; CALCIUM; CRE RECOMBINASE; ENHANCED GREEN FLUORESCENT PROTEIN; GAP JUNCTION PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACENTAL GROWTH FACTOR; THY 1 ANTIGEN; TISSUE INHIBITOR OF METALLOPROTEINASE; VASCULOTROPIN;

ACUTE HEART INFARCTION; ADULT; ADULT STEM CELL; ANGIOGENESIS; BONE MARROW CELL; CELL COMMUNICATION; CELL DEATH; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUSION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; CELL TRANSDIFFERENTIATION; CELL TRANSPLANTATION; CORONARY ARTERY SURGERY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ENZYME ACTIVATION; EX VIVO STUDY; EXCITATION CONTRACTION COUPLING; EXTRACELLULAR MATRIX; FETUS CELL; FETUS HEART; GRAFT REJECTION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART STEM CELL; HEART VENTRICLE TACHYCARDIA; HOST; HUMAN; INTRACORONARY INFUSION; ISCHEMIC HEART DISEASE; KARYOTYPE; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; MULTIPOTENT STEM CELL; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; PARACRINE SIGNALING; PATIENT SAFETY; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SATELLITE CELL; STEM CELL; TISSUE REGENERATION; TISSUE REPAIR; ANIMAL; BONE MARROW TRANSPLANTATION; CYTOLOGY; DISEASE MODEL; FETAL TISSUE TRANSPLANTATION; MOUSE; PATHOPHYSIOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; FETAL TISSUE TRANSPLANTATION; HEART FAILURE; MICE; MYOBLASTS, SKELETAL; MYOCARDIUM; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION; PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 77952987410     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldq005     Document Type: Review

References (65)

1. Soonpaa MH, Koh GY, Klug MG et al. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994;264:98-101.
2. Li RK, Jia ZQ, Weisel RD et al. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 1996;62:654-660
3. Rubart M, Pasumarthi KB, Nakajima H et al. Physiological coupling of donor and host cardi-omyocytes after cellular transplantation. Circ Res 2003;92:1217-1224
4. Taylor DA, Atkins BZ, Hungspreugs P et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-933
5. Collins CA, Olsen I, Zammit PS et al. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 2005;122:289-301.
6. Rubart M, Soonpaa MH, Nakajima H et al. Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest 2004;114:775-783
7. Suzuki K, Murtuza B, Beauchamp JR et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 2004;18:1153-1155 (Pubitemid 39561554)
8. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-705
9. Balsam LB, Wagers AJ, Christensen JL et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668-673
10. Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferenti-ate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-668
11. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003;425:968-973
12. Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 1987;20:263-272
13. Ferrari G, Cusella-De AG, Coletta M et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528-1530
14. Makino S, Fukuda K, Miyoshi S et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705.
15. Dai W, Hale SL, Martin BJ et al. Allogeneic mesenchymal stem cell transplantation in postin-farcted rat myocardium: short-and long-term effects. Circulation 2005;112:214-223
16. Mangi AA, Noiseux N, Kong D et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-1201
17. Nussbaum J, Minami E, Laflamme MA et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 2007;21:1345-1357
18. Laflamme MA, Chen KY, Naumova AV et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007;25:1015-1024
19. van Laake LW, Passier R, Doevendans PA et al. Human embryonic stem cell-derived cardio-myocytes and cardiac repair in rodents. Circ Res 2008;102:1008-1010
20. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676
21. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451:141-146
22. Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-776
23. Moretti A, Caron L, Nakano A et al. Multipotent embryonic isl1\+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006;127:1151-1165
24. Dawn B, Stein AB, Urbanek K et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci USA 2005;102:3766-3771
25. Gonzalez A, Rota M, Nurzynska D et al. Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res 2008;102:597-606.
26. Menasche P, Hagege AA, Scorsin M et al. Myoblast transplantation for heart failure. Lancet 2001;357:279-280
27. Siminiak T, Fiszer D, Jerzykowska O et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J 2005;26:1188-1195
28. Dib N, Michler RE, Pagani FD et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005;112:1748-1755 (Pubitemid 41368151)
29. Hagege AA, Carrion C, Menasche P et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003;361:491-492
30. Menasche P, Alfieri O, Janssens S et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008;117:1189-1200
31. Gavira JJ, Herreros J, Perez A et al. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J Thorac Cardiovasc Surg 2006;131:799-804.
32. Hendrikx M, Hensen K, Clijsters C et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006;114(Suppl 1):I101-7.
33. Stamm C, Kleine HD, Choi YH et al. Intramyocardial delivery of CD133\+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007;133:717-725
34. Ge J, Li Y, Qian J et al. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart 2006;92:1764-1767 (Pubitemid 44851319)
35. Janssens S, Dubois C, Bogaert J et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006;367:113-121
36. Schachinger V, Erbs S, Elsasser A et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221 (Pubitemid 44427445)
37. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 2006;355:1274-1277
38. Chen SL, Fang WW, Ye F et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-95 (Pubitemid 38813459)
39. Kang HJ, Lee HY, Na SH et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 2006;114(Suppl 1):I145-51.
40. Penicka M, Horak J, Kobylka P et al. Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study. J Am Coll Cardiol 2007;49:2373-2374
41. Abdel-Latif A, Bolli R, Tleyjeh IM et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007;167:989-997
42. Lipinski MJ, Biondi-Zoccai GG, Abbate A et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007;50:1761-1767
43. Martin-Rendon E, Brunskill SJ, Hyde CJ et al. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008;29:1807-1818
44. Reffelmann T, Konemann S, Kloner RA. Promise of blood-and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. J Am Coll Cardiol 2009;53:305-308
45. Nadal-Ginard B, Fuster V. Myocardial cell therapy at the crossroads. Nat Clin Pract Cardiovasc Med 2007;4:1.
46. Bartunek J, Dimmeler S, Drexler H et al. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J 2006;27:1338-1340
47. Lee J, Stagg MA, Fukushima S et al. Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes. Am J Physiol Heart Circ Physiol 2009;296:H927-36.
48. del Monte F, O'Gara P, Poole-Wilson PA et al. Cell geometry and contractile abnormalities of myocytes from failing human left ventricle. Cardiovasc Res 1995;30:281-290
49. Davies CH, Davia K, Bennett JG et al. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 1995;92:2540-2549
50. Murtuza B, Suzuki K, Bou-Gharios G et al. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci USA 2004;101:4216-4221
51. Xu X, Xu Z, Xu Y et al. Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats. Coron Artery Dis 2005;16:245-255
52. Kinnaird T, Stabile E, Burnett MS et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004;109:1543-1549
53. Reffelmann T, Dow JS, Dai W et al. Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium. J Mol Cell Cardiol 2003;35:607-613
54. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-436
55. Takahashi M, Li TS, Suzuki R et al. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol 2006;291:H886-93.
56. Gnecchi M, He H, Noiseux N et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006;20:661-669
57. Lee J, Stagg MA, Siedlecka U et al. Identification of cell-specific soluble mediators and cellular targets during cell therapy for the treatment of heart failure. Regen Med 2008;3:953-962
58. Hagege AA, Marolleau JP, Vilquin JT et al. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 2006;114(Suppl 1):I108-13.
59. Siminiak T, Kalawski R, Fiszer D et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 2004;148:531-537
60. Lunde K, Solheim S, Aakhus S et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-1209
61. Meyer GP, Wollert KC, Lotz J et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006;113:1287-1294
62. Meluzin J, Mayer J, Groch L et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J 2006;152:97.e5-15
63. Li ZQ, Zhang M, Jing YZ et al. The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). Int J Cardiol 2007;115:52-56
64. Erbs S, Linke A, Adams V et al. Transplantation of blood-derived progenitor cells after reca-nalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 2005;97:756-762
65. Assmus B, Honold J, Schachinger V et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-1232 (Pubitemid 44427446)